The role for osmotic agents in children with acute encephalopathies: a systematic review.
BACKGROUND
Raised intracranial pressure (ICP) is known to complicate both traumatic and non-traumatic encephalopathies. It impairs cerebral perfusion and may cause death due to global ischaemia and intracranial herniation. Osmotic agents are widely used to control ICP. In children, guidelines for their use are mainly guided by adult studies. We conducted this review to determine the current evidence of the effectiveness of osmotic agents and their effect on resolution of coma and outcome in children with acute encephalopathy.


METHODS
We searched several databases for published and unpublished studies in English and French languages, between January 1966 and March 2009. We considered studies on the use of osmotic agents in children aged between 0 and 16 years with acute encephalopathies. We examined reduction in intracranial pressure, time to resolution of coma, and occurrence of neurological sequelae and death.


RESULTS
We identified four randomized controlled trials, three prospective studies, two retrospective studies and one case report. Hypertonic saline (HS) achieved greater reduction in intracranial pressure (ICP) compared to mannitol and other fluids; normal saline or ringer's lactate. This effect was sustained for longer when it was given as continuous infusion. Boluses of glycerol and mannitol achieved transient reduction in ICP. Oral glycerol was associated with lower mortality and neurological sequelae when compared to placebo in children with acute bacterial meningitis. HS was associated with lower mortality when compared to mannitol in children with non-traumatic encephalopathies.


CONCLUSIONS
HS appears to achieve a greater reduction in ICP than other osmotic agents. Oral glycerol seems to improve outcome among children with acute bacterial meningitis. A sustained reduction in ICP is desirable and could be achieved by modifying the modes and rates of administration of these osmotic agents, but these factors need further investigation.
Gwer
Samson
S
Centre for Geographic Medicine Research (Coast), KEMRI-Wellcome Trust Collaborative Research Programme, Kilifi, Kenya. sgwer@kilifi.kemri-wellcome.org
Gatakaa
Hellen
H
Mwai
Leah
L
Idro
Richard
R
Newton
Charles R
CR
D000208:Acute Disease; D001927:Brain Diseases / Q000188:drug therapy / Q000503:physiopathology*; D002648:Child; D004234:Diuretics, Osmotic / Q000627:therapeutic use*; D005990:Glycerol / Q000627:therapeutic use; D006801:Humans; D019586:Intracranial Hypertension / Q000188:drug therapy*; D007427:Intracranial Pressure / Q000187:drug effects*; D007552:Isotonic Solutions / Q000627:therapeutic use; D008353:Mannitol / Q000627:therapeutic use; D011379:Prognosis; D000077325:Ringer's Lactate; D012462:Saline Solution, Hypertonic / Q000627:therapeutic use; D016896:Treatment Outcome
D004234:Diuretics, Osmotic; D007552:Isotonic Solutions; D000077325:Ringer's Lactate; D012462:Saline Solution, Hypertonic; D008353:Mannitol; D005990:Glycerol
J Pediatr Surg. 2006 Jan;41(1):83-7; discussion 83-7
16410113
Crit Care Med. 2003 Jun;31(6):1683-7
12794404
Acta Neurochir (Wien). 1977;36(3-4):189-200
848367
Acta Neurochir Suppl. 1998;71:22-6
9779133
Clin Infect Dis. 2007 Nov 15;45(10):1277-86
17968821
J Trauma. 2002 Sep;53(3):558-63
12352497
Indian Pediatr. 2006 Sep;43(9):771-9
17033115
Clin Infect Dis. 2004 Feb 1;38(3):384-90
14727209
Acta Neurochir (Wien). 1980;51(3-4):161-72
6768226
Crit Care Med. 2000 Apr;28(4):1136-43
10809295
J Neurosurg. 1992 Jan;76(1):91-8
1727174
Arch Dis Child. 1983 Mar;58(3):184-6
6838249
J Neurosurg. 2004 May;100(5 Suppl Pediatrics):454-9
15287454
Agressologie. 1991;32(8-9 Spec No):381-5
1844198
J Neurosurg. 1982 Mar;56(3):323-31
7057229
Arch Dis Child. 1997 Mar;76(3):219-26
9135262
Brain. 2002 May;125(Pt 5):1084-93
11960897
Neurology. 1982 Apr;32(4):437-40
6801542
Acta Neurochir Suppl. 2006;96:114-8
16671437
Pharmacol Ther. 1998 Jul;79(1):1-53
9719344
J Neurosurg Sci. 1982 Jul-Sep;26(3):193-8
7182440
Pediatrics. 1977 Apr;59(4):606-13
850600
Can J Anaesth. 1996 May;43(5 Pt 1):461-6
8723852
Crit Care Med. 2000 Apr;28(4):1144-51
10809296
J Trop Med Hyg. 1971 Nov;74(11):249-52
5126296
Malar J. 2007 Oct 24;6:138
17958887
J Neurosurg. 2002 Nov;97(5):1045-53
12450025
Acta Neurochir Suppl (Wien). 1990;51:324-5
2128579
J Neurosurg. 1978 Feb;48(2):169-72
624964
J Neurosurg Anesthesiol. 1992 Jan;4(1):4-10
15815431
Intensive Care Med. 2001 Jan;27(1):236-9
11280641
Toxicol Appl Pharmacol. 1999 Apr 15;156(2):96-105
10198274
Neurosurgery. 2002 Apr;50(4):774-9; discussion 779-80
11904028
Neurol Res. 2010 Mar;32(2):139-43
19309542
Crit Care Med. 1998 Jul;26(7):1265-70
9671379